{"id":19973,"date":"2024-02-22T19:02:41","date_gmt":"2024-02-22T06:02:41","guid":{"rendered":"https:\/\/clladvocates.nz\/?p=19973"},"modified":"2024-02-22T19:06:43","modified_gmt":"2024-02-22T06:06:43","slug":"combo-of-drugs-could-be-used-to-treat-chronic-lymphocytic-leukaemia-patients","status":"publish","type":"post","link":"https:\/\/clladvocates.nz\/?p=19973","title":{"rendered":"Combo of drugs could be used to treat Chronic Lymphocytic Leukaemia patients"},"content":{"rendered":"<p>A medicine regime that can be taken at home could mean patients suffering from chronic lymphocytic leukaemia will be much less likely to need hospital chemotherapy.<\/p>\n<p>About 320 people are diagnosed in New Zealand each year with chronic lymphocytic leukaemia &#8211; referred to as CLL.<\/p>\n<p>It is the most common form of leukaemia in this country.<\/p>\n<p>But two major leukaemia studies presented at a recent global blood cancer conference in December, the American Society of Haematology, have shown the use of the drug IMBRUVICA in combination with venetoclax can be successful\u00a0as a first option of treatment for CLL patients.<\/p>\n<p>The drugs have been used to treat CLL separately but the two recent studies &#8211; named CAPTIVATE and GLOW &#8211; found their combination was highly successful in treating patients.<\/p>\n<p>Patients took the drugs over 15 months and 97 per cent in one study and 84.5 per cent in the other were still alive after five years.<\/p>\n<p>Listen to haematologist Dr Sharon Jackson from Middlemore Hospital and patient Kylie Soo, who is now in remission discuss the treatment regime: <a href=\"https:\/\/www.rnz.co.nz\/national\/programmes\/ninetonoon\/audio\/2018927134\/combo-of-drugs-could-be-used-to-treat-leukaemia-patients\">Combo of drugs could be used to treat leukaemia patients<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>A medicine regime that can be taken at home could mean patients suffering from chronic lymphocytic leukaemia will be much [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":19974,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[12,17],"tags":[91,92,93,94,47,48,49,51,52,74,90],"class_list":["post-19973","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-media","category-featured","tag-ventoclax","tag-nine-to-noon","tag-american-society-of-haematology","tag-zanubrutinib-sonrotoclax","tag-chronic-lymphocytic-leukemia","tag-ibrutinib","tag-pharmac-review-panel","tag-imbruvica","tag-venclaxta","tag-patient-voice-aotearoa","tag-dr-sharon-jackson-kylie-soo"],"jetpack_featured_media_url":"https:\/\/clladvocates.nz\/wp-content\/uploads\/2024\/02\/Leukaemia_Cells.png","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/clladvocates.nz\/index.php?rest_route=\/wp\/v2\/posts\/19973","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clladvocates.nz\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/clladvocates.nz\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/clladvocates.nz\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/clladvocates.nz\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=19973"}],"version-history":[{"count":2,"href":"https:\/\/clladvocates.nz\/index.php?rest_route=\/wp\/v2\/posts\/19973\/revisions"}],"predecessor-version":[{"id":19979,"href":"https:\/\/clladvocates.nz\/index.php?rest_route=\/wp\/v2\/posts\/19973\/revisions\/19979"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/clladvocates.nz\/index.php?rest_route=\/wp\/v2\/media\/19974"}],"wp:attachment":[{"href":"https:\/\/clladvocates.nz\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=19973"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/clladvocates.nz\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=19973"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/clladvocates.nz\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=19973"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}